Obsessive-compulsive disorder in the perinatal period: A review of the literature

Current Psychiatry Reviews

Volumn 3, Issue 4, 2007, Pages 265-270

  Misri, Shaila ^a   Kendrick, Kristin ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Anxiety; Obsessive compulsive disorder; Perinatal; Postpartum; Pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; LORAZEPAM; QUETIAPINE; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AVOIDANCE BEHAVIOR; CLINICAL TRIAL; COGNITIVE THERAPY; COMPULSION; DELIVERY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE EXACERBATION; FEAR; FEMALE; HUMAN; MONOTHERAPY; OBSESSIVE COMPULSIVE DISORDER; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SYMPTOM;

EID: 36249022219     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340007782408905     Document Type: Review

References (59)

1. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders, 4th edition, text revision (DSM-IVTR). Washingibn, DC, American Psychiatric Press, Inc. 2000.
2. Karno M, Golding JM, Sorenson SB, Burnam A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988; 45: 1094-9.
3. Sutter-Dallay AL, Giaconne-Marcesche V, Glatigny-Dallay E, Verdoux H. Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective study of the MATQUID cohort. Eur Psychiatry 2004; 19: 459-63.
4. Zar M, Wijma K, Wijma B. Relations-between anxiety disorders and-fear of childbirth during late pregnancy. Clin Psychol Psychother 2002; 9: 122-30.
5. Wenzel A, Gorman LL, O'Hara MW, Swart S. The occurrence of panic and obsessive compulsive symptoms in women with postpartum dysphoria: a prospective study. Arch Womens Ment Health 2001; 4: 5-12.
6. Wenzel A, Haugen EN, Jackson LC, Brendle JR. Anxiety symptoms and disorders at eight weeks postpartum. J Anxiety Disord 2005; 19: 295-311.
7. Uguz F, Akman C, Kaya N, Cilli AS. Postpartum-onset obsessive-compulsive disorder: incidence, clinical features, and related factors. J Clin Psychiatry 2007; 68: 132-8.
8. Abramowitz JS, Schwartz SA, Moore KM. Obsessional thoughts in postpartum females and their partners: content, severity, and relationship with depression. J Chn Psychol Med Settings 2003; 10: 157-64.
9. Jennings KD, Ross S, Pepper S, Elmore M. Thoughts of harming infants in depressed and nondeprcssed mothers. J Affect Disord 1999; 54: 21-8.
10. Labad J, Menchon JM, Alonso P, Segalas C, Jimenez S, Vallejo J. Female reproductive cycle and obscssivc-compulsive disorder. J Clin Psychiatry 2005; 66 (quiz 546): 428-35.
11. Arnold LM. A case series of women with postpartum-onset obsessive-compulsive disorder. Primary Care Companion J Clin Psychiatry 1999; 1: 103-8.
12. Sichel DA, Cohen LS, Dimmock JA, Rosenbaum JF. Postpartum obsessive-compulsive disorder: a case series. J Clin Psychiatry 1993; 54: 156-9.
13. Williams K, Koran L. Obsessive-compulsive disorder in pregnancy, the puerpcrium, and the premenstrual. J Clin Psychiatry 1997; 58: 330-4.
14. Wisner KL, Peindl KS, Gigliotti T, Hanusa BH. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry 1999; 60: 176-80.
15. Abramowitz JS, Schwartz SA, Moore KM, Luenzmann KR. Obsessive-compulsive symptoms in pregnancy and the puerperium: A review of the literature. J Anxiety Disord 2003; 17: 461-78.
16. Fairbrother N, Abramowitz JS. New parenthood as a risk factor for the development of obsessional problems. Behav Res Ther 2006; retrieved from doi: 10.1016/j.brat.2006.09.019 June 12, 2007.
17. Suri R, Burt V. The assessment and treatment of postpartum psychiatric disorders. Journal of Practice in Psychiatry and Behavioral Health 1997; 3: 67-77.
18. Spinelli MG. Maternal infanticide associated with mental illness: prevention and the promise of saved lives. Am J Psychiatry 2004; 161: 1548-57.
19. Buttolph ML, Holland AD. Obsessive-compulsive disorders in pregnancy and childbirth. In: Jenike M, Baer L, Minichiello W Eds, Obsessive-compulsive disorders: theory and management. Chicago, Year Book Medical. 1990; 89-97.
20. Neziroglu F, Anemone R, Yaryura-Tobias J. Onset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry 1992; 149: 947-50.
21. Mania G, Albert U, Bogetto F, Vaschetto P, Ravizza L. Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/delivery. Psychiatry Res 1999; 89: 49-58.
22. Vulink NCC, Denys D, Bus L, Westenberg HGM. Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol 2006; 21: 171-5.
23. Hertzberg T, Leo RJ, Kim KY. Recurrent obsessive-compulsive disorder associated with pregnancy and childbirth. Psychosomatics 1997; 38: 386-8.
24. Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive-compulsive disorder. Int Clin Psychopharmacol 1993; 8(Suppl 2): 79-82.
25. Leckman J, Goodman W, North W, et al. The role of central oxytocin in obsessive-compulsive disorder and related normal behavior. Psychoneuroendocrinology 1994; 19: 723-49.
26. Diaz SF, Grush LR, Sichel DA, Cohen LS. Obsessive-compulsive disorder in pregnancy and the puerperium. In: Dickstein LJ, Riba MB, Oldham JM Eds, Review of psychiatry. Washington, DC, American Psychiatric Press. 1997; 16: 97-111
27. Salkovskis P. Cognitive-behavioral approaches to the understanding of obsessional problems. In: Rapee RM Ed, Current controversies in the anxiety disorders. New York, Guilford Press. 1996; 103-33.
28. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-oompulsive disorder: a quantitative review of the controlled treatment literutwe. J Consult Clin Psychol 1997; 65: 44-52.
29. Brandes M, Soares CN, Cohen LS. Postpartum onset obsessive-compulsive disorder: diagnosis and management. Arch Womens Ment Health 2004; 7:99-110.
30. Misri S, Milis L. Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation. J Clin Psychopharmacol 2004; 24: 624-7.
31. Chelmow D, Halfin VP. Pregnancy complicated by obsessive-compulsive disorder. J Matem-Fetal Med 1997; 6: 31-4.
32. Sichel DA, Cohen LS, Rosenbaum JF, Driscoll JD. Postpartum onset of obsessive-compulsive disorder. Psychosomatics 1993; 34: 277-9.
33. McDonough M, Kennedy N. Pharmacological management of obsessive-compulsive disorder: a review for clinicians. Harvard Rev Psychiatry 2002; 10: 127-37.
34. Taylor TM, O'Toole MS, Ohlsen RI, Walters J, Pilowsky LS. Safety of quetiapine during pregnancy. Am J Psychiatry 2003; 160: 588-9.
35. Tenyi T, Trixler M, Keresztes Z. Quetiapine and pregnancy. Am J Psychiatry 2002; 159: 674.
36. Lee A, Giesbrecht E, Dunn E, Ito S. Excretion of quetiapine in breast milk. Am J Psychiatry 2004; 161: 1715-6.
37. Misri S, Corral M, Wardrop AA, Kendrick K. Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharm 2006; 26: 508-11.
38. Schimmell MS, Katz EZ, Shaag Y, Pastuszak A, Koren G. Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 1991; 29: 479-84.
39. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336: 258-62.
40. Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159: 1889-95.
41. Yoshida K, Smith B, Craggs M, Kumar RC. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 1997; 43: 225-37.
42. Hendrick V, Stowe ZN, Altshulex LL, Hwang S, Lee E. Haynes D. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160: 993-6.
43. Kim J, Riggs KW, Misri S, et al. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. Br J Clin Psychopharm 2006; 61: 155-63.
44. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005; 14: 63-7.
45. Goldstein DJ, Colbin LA, Sundell KL. Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997; 89: 713-8.
46. McElhatton PR, Garbis HM, Elefant E, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Servides (ENTIS). Reprod Toxicol 1996; 10: 285-94.
47. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010-5.
48. Mhanna MJ, Bennet JB 2nd, Izatt SD. Potential fluoxetine chloride (Prozac) toxicity in a newborn. Pediatrics 1997; 100: 158-9.
49. Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001; 158: 1001-9.
50. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 1999; 104: e61.
51. Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993; 32: 1253-5.
52. Gentile S. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf2005; 28:137-52.
53. Neziroglu F, Henricksen J, Yaryura-Tobias JA. Psychotherapy of obsessive-compulsive disorder and spectrum: established facts and advances, 1995-2005. Psychiatr Clin N Am 2006; 29: 585-604.
54. Expert Consensus Panel for Obsessive-Compulsive Disorder. Treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997; 58(suppl 4): 2-72.
55. Misri S, Reebye P, Corral M, Milis L. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 2004; 65: 1236-41.
56. Ross LE, McLean LM. Anxiety disorders during pregnancy and the postpartum period: A systematic review. J Clin Psychiatry 2006; 67: 1285-98.
57. Rennie R, Landreth G. Effects of filial therapy on parent and child behaviors. International Journal of Play Therapy 2000; 9: 19-37:
58. Lee HK. The effects of infant massage on weight, height, and mother-infant interaction. Daehan Ganho Haghoeji 2006; 36: 1331-9.
59. Brockington IF, Macdonald E, Wainscott G. Anxiety, obsessions and morbid preoccupations in pregnancy and the puerperium. Arch Womens Ment Health 2006; 9: 253-263.